Todd Ludwig, MD
Sports Medicine · Flagstaff, AZNPI 1154783553
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (35.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Corentec America Inc at 45.8% of the total. 2025 is the largest year on record at $4,855, more than ten times the $176 reported in 2019.
Across 73 payments — averaging $155.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corentec America Inc$5K
- Arthrex$3K
- Gemini Mountain Medical, LLC$2K
- Stryker$426
- Smith+Nephew$284
- Vericel Corporation$283
- plus $896 from 7 others
What the payments were for
- Consulting fees$1,50013%
- Travel & lodging$3,41030%
- Food & beverage$4,05536%
- Education$2,40021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corentec America Inc | 10 | $5,210 |
| Arthrex | 22 | $2,562 |
| Gemini Mountain Medical, LLC | 4 | $1,706 |
| Stryker | 6 | $426 |
| Smith+Nephew | 3 | $284 |
| Vericel Corporation | 12 | $283 |
| Medical Device Business Services, Inc. | 4 | $264 |
| Catalyst Orthoscience | 1 | $172 |
| Impactortho, Inc. | 3 | $164 |
| Johnson & Johnson | 2 | $123 |
| Next Science LLC | 1 | $90 |
| Boston Scientific | 3 | $53 |
| Ferring Pharmaceuticals Inc. | 2 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Corentec$5,035
- REAL INTELLIGENCE$276
- Catalyst CSR Shoulder System$172
- MAKO$154
- Journey II$141
How this compares
$11,365 in reported general payments places this provider in the 70th percentile of 152 sports medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 101 | $2,057 |
| Meloxicam | 169 | $498 |
| Oxycodone Hcl | 35 | $187 |
| Mupirocin | 16 | $106 |
| Tramadol Hcl | 33 | $99 |
| Amoxicillin | 27 | $39 |
| Ondansetron Hcl | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Flagstaff
- Darius MoezziFlagstaff$7K
- Anup ShahPhoenix$1.3M
- Amon FerryScottsdale$482K
- John TokishScottsdale$387K
- John BrownSun City West$258K
- Shelden MartinChandler$208K
- Kyle ChunPrescott Valley$160K
- Matthew HansenGilbert$84K
- Jeffrey AbildgaardGilbert$74K
- Chris LutherTucson$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.